Edition:
United Kingdom

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

1.52USD
13 Dec 2018
Change (% chg)

$-0.09 (-5.59%)
Prev Close
$1.61
Open
$1.65
Day's High
$1.65
Day's Low
$1.50
Volume
200,813
Avg. Vol
128,155
52-wk High
$7.94
52-wk Low
$1.49

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.15 December 14 Dec 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 3 3 3 4
(3) HOLD 1 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 1.60 1.60 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5 8.63 10.00 6.12 10.50
Quarter Ending Mar-19 2 8.00 8.50 7.50 --
Year Ending Dec-18 5 34.81 36.18 32.30 60.34
Year Ending Dec-19 5 41.87 80.80 24.25 71.92
Earnings (per share)
Quarter Ending Dec-18 5 -0.15 -0.09 -0.25 -0.13
Quarter Ending Mar-19 2 -0.12 -0.08 -0.17 --
Year Ending Dec-18 5 -0.61 -0.55 -0.72 0.75
Year Ending Dec-19 5 -0.17 1.02 -0.66 1.75

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 9.78 7.67 2.11 21.62
Quarter Ending Jun-18 9.09 8.77 0.32 3.50
Quarter Ending Mar-18 8.88 9.74 0.86 9.70
Quarter Ending Dec-17 9.66 8.80 0.86 8.86
Quarter Ending Sep-17 16.06 9.56 6.50 40.46

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 8.63 8.51 8.51 8.69 10.50
Quarter Ending Mar-19 8.00 8.00 8.00 7.50 --
Year Ending Dec-18 34.81 34.81 34.81 36.87 60.34
Year Ending Dec-19 41.87 46.87 46.87 41.14 71.92

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 1 0 1 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 1 0 1
Earnings